A Phase I Study of the Mass Balance of a Single Oral Administration of [14C]TPN171H in Healthy Male Subjects
Latest Information Update: 01 Mar 2021
Price :
$35 *
At a glance
- Drugs Simmerafil (Primary)
- Indications Erectile dysfunction; Pulmonary arterial hypertension
- Focus Pharmacokinetics
- Sponsors Vigonvita Life Sciences
- 24 Feb 2021 Status changed from recruiting to completed.
- 14 Dec 2020 New trial record